Charles River lays out $293M to snap up viral vector specialist Vigene, its 2nd M&A deal this year

A few short months after Charles River Laboratories acquired Cognate BioServices, the company is folding yet another CDMO into its cell and gene network, signing more than $ 1 billion in M&A outlays so far this year.  Charles River Laboratories has inked a deal to pay $ 292.5 million in cash for gene therapy CDMO Vigene Biosciences,… Read More »

Breast Cancer Rates Fell When Regular Hormone Therapy Decreased

Breast cancer rates dropped by half in tandem with the discontinuation of hormone replacement therapy, according to a study published online in the Journal of the National Cancer Institute. The study was reported in the Telegraph in the United Kingdom. The Telegraph said: “Dr Prithwish De, of the Canadian Cancer Society, and colleagues, found that… Read More »

3 Myths About Running and Your Health

Every person who takes up running has been confronted by a “helpful” critic who is more than happy to reel off the reasons running will ruin your life. Here’s a look at three questionable claims about running and health: 1. Running will give you a heart attack or other heart problems. It is true that… Read More »